← Leaderboards
Sicinska
Dana-Farber Cancer Inst
$1,156,101
Attributed
$1,156,101
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $360.7K · FY2020–23$500K$375K$250K$125K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$1,156,101 · 2
By mechanism
P50$1,156,101 · 2
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Nathanael Schiander Gray$36,761,550
- Jeffrey Wade Harper$36,219,392
- Laurie H Glimcher$56,303,115
- Peter M Howley$39,809,224
- Alan David D'andrea$28,094,196
Others in their field
Other Emerging Leaders on “Aftercare”
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,888,963
- Bronwen Shaw · Medical College Of Wisconsin$19,182,557
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$13,559,983
- Ki Young Chung · Prisma Health - Upstate$8,495,983
- Deanna A Kulpa · Emory University$8,444,989
Research focus
AftercareApplications GrantsAutopsyAntibodiesBiologicalBiopsyBloodCancer CenterCancer ModelCareerCell LineCellsCellular ImagingCellularityCholangiocarcinomaClinical DataClinical TrialsCollaborationsComplementConsentDrug TestingEnrollmentEnsureEvaluation
Grant awards (4)
Core B - Pathology and Biospecimen Core$324,787
P50 · FY2023 · CA · contact PI
Core B - Pathology and Biospecimen Core$360,700
P50 · FY2022 · CA · contact PI
Core B - Pathology and Biospecimen Core$207,657
P50 · FY2021 · CA · contact PI
Core B - Pathology and Biospecimen Core$262,957
P50 · FY2020 · CA · contact PI